SOLNA, STOCKHOLM REGION, SWEDEN — November 28, 2025 — Barnik Invest is pleased to announce the expansion of its business development operations into North America by assigning Soroosh Ghahremani as Business Development Consultant in Toronto, Canada. Soroosh brings years of sales and marketing experience and will be responsible for out-reach to North American VCs and family offices. This expansion marks a natural progression in the firm’s mission to connect innovative Nordic Life Science companies with the investment landscape and strategic partnership opportunities available across the North American market.
Through this assignment, Barnik Invest aims to create a dedicated bridge for the exchange of innovation and capital. This initiative is designed to introduce cutting-edge technologies to accredited investors and partners, fostering a professional ecosystem where Nordic innovation meets North American strategic investment.
For more information, please contact;
Hamid Bakhshi, CEO
Telephone: +46738531165
E-mail: info@barnikinvest.com
About Barnik Invest Group
Barnik Invest Group is a leading 360 solution partner for Life Science companies in the Nordics. The company provides a comprehensive suite of services to support its portfolio companies, including capital, clinical development, expertise, and commercialization. Through its fully owned subsidiaries, Medicorent and StartUpPharma, Barnik Invest offers CRO services, outsourcing, recruitment, distribution, product development, and commercialization solutions. Barnik’s mission is to nurture promising life science companies from early clinical development to commercialization, enabling them to achieve positive cash flows or successful exits, and ultimately enhancing patient well-being and improving human health worldwide. For more information, visit www.barnikinvest.com.
